vs
INTERGROUP CORP(INTG)与Protalix BioTherapeutics, Inc.(PLX)财务数据对比。点击上方公司名可切换其他公司
INTERGROUP CORP的季度营收约是Protalix BioTherapeutics, Inc.的1.9倍($17.3M vs $9.1M),INTERGROUP CORP净利率更高(8.8% vs -60.3%,领先69.1%),INTERGROUP CORP同比增速更快(19.8% vs -49.9%),Protalix BioTherapeutics, Inc.自由现金流更多($1.6M vs $-481.0K),过去两年INTERGROUP CORP的营收复合增速更高(7.8% vs -6.7%)
Intergroup Corp是一家多元化控股企业,核心业务覆盖房地产与酒店运营两大板块。公司在美国境内持有、管理及租赁商住类物业,同时运营面向休闲和商务旅客的有限服务型酒店。
Protalix BioTherapeutics是一家以色列制药企业,核心产品为植物源酶制剂他利苷酶阿尔法,该产品已获美国食品药品监督管理局批准,用于治疗戈谢病,专注于开发创新生物技术药物服务患者需求。
INTG vs PLX — 直观对比
营收规模更大
INTG
是对方的1.9倍
$9.1M
营收增速更快
INTG
高出69.7%
-49.9%
净利率更高
INTG
高出69.1%
-60.3%
自由现金流更多
PLX
多$2.1M
$-481.0K
两年增速更快
INTG
近两年复合增速
-6.7%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $17.3M | $9.1M |
| 净利润 | $1.5M | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | 11.6% | -51.1% |
| 净利率 | 8.8% | -60.3% |
| 营收同比 | 19.8% | -49.9% |
| 净利润同比 | 155.6% | -184.8% |
| 每股收益(稀释后) | $0.71 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
INTG
PLX
| Q4 25 | $17.3M | $9.1M | ||
| Q3 25 | $17.9M | $17.9M | ||
| Q2 25 | $16.2M | $15.7M | ||
| Q1 25 | $16.8M | $10.1M | ||
| Q4 24 | $14.4M | $18.2M | ||
| Q3 24 | $16.9M | $18.0M | ||
| Q2 24 | $13.4M | $13.5M | ||
| Q1 24 | $14.9M | — |
净利润
INTG
PLX
| Q4 25 | $1.5M | $-5.5M | ||
| Q3 25 | $-535.0K | $2.4M | ||
| Q2 25 | $-2.2M | $164.0K | ||
| Q1 25 | $-578.0K | $-3.6M | ||
| Q4 24 | $-2.7M | $6.5M | ||
| Q3 24 | $-398.0K | $3.2M | ||
| Q2 24 | $-4.9M | $-2.2M | ||
| Q1 24 | $-3.2M | — |
毛利率
INTG
PLX
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
营业利润率
INTG
PLX
| Q4 25 | 11.6% | -51.1% | ||
| Q3 25 | 15.3% | 11.9% | ||
| Q2 25 | 8.1% | 7.5% | ||
| Q1 25 | 14.0% | -41.0% | ||
| Q4 24 | 5.9% | 39.6% | ||
| Q3 24 | 18.5% | 22.2% | ||
| Q2 24 | 3.7% | -18.0% | ||
| Q1 24 | 4.8% | — |
净利率
INTG
PLX
| Q4 25 | 8.8% | -60.3% | ||
| Q3 25 | -3.0% | 13.2% | ||
| Q2 25 | -13.9% | 1.0% | ||
| Q1 25 | -3.4% | -35.8% | ||
| Q4 24 | -18.9% | 35.6% | ||
| Q3 24 | -2.4% | 18.0% | ||
| Q2 24 | -36.7% | -16.4% | ||
| Q1 24 | -21.3% | — |
每股收益(稀释后)
INTG
PLX
| Q4 25 | $0.71 | $-0.06 | ||
| Q3 25 | $-0.25 | $0.03 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | $-0.27 | $-0.05 | ||
| Q4 24 | $-1.26 | $0.10 | ||
| Q3 24 | $-0.18 | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | $-1.44 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $7.5M | $14.7M |
| 总债务越低越好 | $233.2M | — |
| 股东权益账面价值 | $-85.2M | $48.2M |
| 总资产 | $101.1M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
INTG
PLX
| Q4 25 | $7.5M | $14.7M | ||
| Q3 25 | $6.0M | $13.6M | ||
| Q2 25 | $6.1M | $17.9M | ||
| Q1 25 | $4.8M | $19.5M | ||
| Q4 24 | $15.4M | $19.8M | ||
| Q3 24 | $12.2M | $27.4M | ||
| Q2 24 | $11.6M | $23.4M | ||
| Q1 24 | $19.5M | — |
总债务
INTG
PLX
| Q4 25 | $233.2M | — | ||
| Q3 25 | $237.8M | — | ||
| Q2 25 | $240.5M | — | ||
| Q1 25 | $241.5M | — | ||
| Q4 24 | $227.2M | — | ||
| Q3 24 | $218.1M | — | ||
| Q2 24 | $225.7M | — | ||
| Q1 24 | $225.0M | — |
股东权益
INTG
PLX
| Q4 25 | $-85.2M | $48.2M | ||
| Q3 25 | $-86.7M | $52.9M | ||
| Q2 25 | $-86.1M | $49.9M | ||
| Q1 25 | $-84.5M | $45.2M | ||
| Q4 24 | $-83.9M | $43.2M | ||
| Q3 24 | $-80.9M | $32.4M | ||
| Q2 24 | $-80.3M | $28.6M | ||
| Q1 24 | $-76.4M | — |
总资产
INTG
PLX
| Q4 25 | $101.1M | $82.3M | ||
| Q3 25 | $102.5M | $82.3M | ||
| Q2 25 | $104.1M | $78.5M | ||
| Q1 25 | $103.2M | $73.9M | ||
| Q4 24 | $110.6M | $73.4M | ||
| Q3 24 | $109.3M | $61.6M | ||
| Q2 24 | $107.8M | $91.5M | ||
| Q1 24 | $119.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-23.0K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-481.0K | $1.6M |
| 自由现金流率自由现金流/营收 | -2.8% | 17.8% |
| 资本支出强度资本支出/营收 | 2.6% | 4.4% |
| 现金转化率经营现金流/净利润 | -0.02× | — |
| 过去12个月自由现金流最近4个季度 | $739.0K | $-13.6M |
8季度趋势,按日历期对齐
经营现金流
INTG
PLX
| Q4 25 | $-23.0K | $2.0M | ||
| Q3 25 | $-296.0K | $-3.7M | ||
| Q2 25 | $5.9M | $-5.2M | ||
| Q1 25 | $-854.0K | $-5.1M | ||
| Q4 24 | $-781.0K | $4.0M | ||
| Q3 24 | $3.4M | $4.1M | ||
| Q2 24 | $6.8M | $-3.6M | ||
| Q1 24 | $1.9M | — |
自由现金流
INTG
PLX
| Q4 25 | $-481.0K | $1.6M | ||
| Q3 25 | $-1.3M | $-4.2M | ||
| Q2 25 | $3.6M | $-5.7M | ||
| Q1 25 | $-1.2M | $-5.4M | ||
| Q4 24 | $-1.1M | $3.6M | ||
| Q3 24 | $3.1M | $4.0M | ||
| Q2 24 | $2.7M | $-3.8M | ||
| Q1 24 | $1.1M | — |
自由现金流率
INTG
PLX
| Q4 25 | -2.8% | 17.8% | ||
| Q3 25 | -7.1% | -23.7% | ||
| Q2 25 | 22.5% | -36.2% | ||
| Q1 25 | -6.8% | -53.0% | ||
| Q4 24 | -7.8% | 19.6% | ||
| Q3 24 | 18.3% | 22.4% | ||
| Q2 24 | 20.4% | -28.1% | ||
| Q1 24 | 7.6% | — |
资本支出强度
INTG
PLX
| Q4 25 | 2.6% | 4.4% | ||
| Q3 25 | 5.4% | 2.8% | ||
| Q2 25 | 13.9% | 2.8% | ||
| Q1 25 | 1.8% | 3.0% | ||
| Q4 24 | 2.4% | 2.3% | ||
| Q3 24 | 1.6% | 0.5% | ||
| Q2 24 | 30.4% | 1.3% | ||
| Q1 24 | 4.9% | — |
现金转化率
INTG
PLX
| Q4 25 | -0.02× | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |